ArticlePakistan journal of medical sciences2025
Predictive Value of Transabdominal Ultrasonography in Detecting Extrahepatic Bile Duct Obstructive Lesions Compared with Endoscopic Retrograde Cholangiopancreatography.
Article in Pakistan journal of medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background & Objective: Transabdominal ultrasonography (TAUS) remains the initial imaging modality in diagnosis of bile duct obstructive lesions. The purpose of this study was to investigate the predictive value of TAUS in detecting bile duct obstructive lesions in comparison with endoscopic retrograde cholangiopancreatography (ERCP) as the standard method. Methods: This retrospective descriptive study analyzed the electronic records of the patients diagnosed with obstructive jaundice from April 2017 to November 2022 at Alsafwa Consultative Medical Center in Almukalla City, Hadhramout, Yemen. All patients involved were diagnosed by TAUS and the diagnosis was confirmed by ERCP. A comparison of the diagnoses was performed. Results: TAUS and ERCP demonstrated high compatibility in bile duct obstructive lesions, with substantial agreement in detecting cholangiocarcinoma, bile duct stricture, stones, pancreatic cancer, and ampulla of Vater mass (compatibility ranging from 71.4% to 100%, Cohen's Kappa = 0.748, Conclusion: TAUS is a reliable and highly valuable imaging modality for detecting and determining the cause and level of bile duct obstruction in patients with obstructive jaundice which offers a non-invasive approach, radiation free, with minimal risk of serious complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.